<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig0001">
 <label>Figure 1</label>
 <caption>
  <p>Overlapping cytokine profiles described in patients with COVID-19, CRS, sHLH and IRIS suggest pathophysiological similarities and potential for shared therapeutic interventions. CCL = chemokine ligand, COVID-19 = coronavirus disease 2019, CRP = C-reactive protein, CRS = Cytokine release syndrome, CXCL = CXC chemokine ligand, FGF = fibroblast growth factor, G-CSF = granulocyte colony-stimulating factor, GMCSF = Granulocyte-macrophage colony-stimulating factor, IFN-γ = interferon γ, IL = interleukin, IP = induced protein, IRIS = Immune Reconstitution Inflammatory Syndrome, MCP = monocyte chemoattractant protein, MIP = macrophage inflammatory protein, PDGF = Platelet-derived growth factor, sHLH = Secondary hemophagocytic lymphohistiocytosis, TNF- α = tumor necrosis factor α, VEGF = vascular endothelial growth factor. References: Huang. Lancet 2020 (COVID-19); Brudno. Blood 2019 (CAR-T); Gopal. Eur Resp Review 2017 (IRIS); Schulert. Best Practice Rheum 2014 (sHLH). (Color version of figure is available online).</p>
 </caption>
 <alt-text id="alt0001">Figure 1</alt-text>
 <graphic xlink:href="gr1_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
